TCT 2023 Late-Breaking Science Collection
Published: 09 January 2024
-
Views:
224
-
Likes:
7
-
Views:
224
-
Likes:
7
-
25m 48sPart 1 | Session 1 View from the Thoraxcenter: TCT 23 Late-breaking Science Preview Nicolas M Van Mieghem, Joost Daemen
-
30m 36sPart 1 | Session 2 View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up Nicolas M Van Mieghem, Joost Daemen
-
8m 13sPart 2 | Session 1 5 Trials That Will Change My Practice With Dr Kendra Grubb Kendra J Grubb
-
14m 10sPart 2 | Session 2 5 Trials That Will Change My Practice With Dr Mirvat Alasnag Mirvat Alasnag
-
12m 36sPart 2 | Session 3 5 Trials That Will Change My Practice With Dr Bernardo Cortese Bernardo Cortese
-
7m 42sPart 3 | Session 1 5Y Outcomes From the PARTNER 3 Low-Risk Trial
-
6m 43sPart 3 | Session 2 AGENT IDE: AGENT Paclitaxel Coated Balloon Angioplasty for In-Stent Restenosis Robert Yeh
-
8m 46sPart 3 | Session 3 Four-Year Outcomes from the EVOLUT Low Risk Trial Michael J Reardon
-
11m 22sPart 3 | Session 4 PICSO-AMI-I: Pressure Controlled Intermittent Coronary Sinus Occlusion in Acute Myocardial Infarction Giovanni Luigi Di Maria
-
6m 19sPart 3 | Session 5 WATCH-TAVR: WATCHMAN for Patients with AF Undergoing TAVR Samir R Kapadia
Overview
Stay up-to-date with our regular review series, View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this #TCT2023 edition they provide a short analysis of the most pertinent data from the late-breaking science presentations.
Short, accessible Expert Interviews were conducted with investigators focusing on study design, key results and applicability of the latest data.
More from this programme
Part 1
View from the Thoraxcenter
Part 2
Highlights
Part 3
Interviews
About the episode
TCT 23 - We are joined by Dr Matthias Götberg (Lund University, SE) to discuss recent findings from a study of the SWEDEHEART Registry, where the long-term outcomes of iFR vs FFR guided coronary revascularization were compared.
Results suggest that in a national registry analysis of 42887 patients investigated with iFR or FFR with 5-year follow-up, similar outcomes were observed in MACE, all-cause death, myocardial infarction, unplanned revascularization and deferred and treated populations.
Interview Questions:
- What was the reasoning behind this study?
- What was the patient cohort and study design?
- What were the key findings?
- What are your take-home messages?
- What further study is still required?
Recorded remotely from Lund, 2023.
Editor: Jordan Rance
Video Specialist: Tom Green
Comments